Quantcast

Posts related to ‘Avastin’

Media Digest (12/17/2010) Reuters, WSJ, NYT, FT, Bloomberg

Posted: December 17, 2010 at 4:07 am

Congress passed the Obama tax program. (Reuters) Global M&A moved above $2.2 trillion in 2010. (Reuters) Moody's cut Ireland to Baa1. (Reuters) NSA's Information Assurance Directorate, which protects US data, ...
Read Full Story »

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Posted: January 14, 2008 at 12:33 pm

Genentech (NYSE: DNA) is set to report earnings after the close today.  First Call has estimates pegged at $0.67 EPS on revenues of $2.97 Billion.  This will also mark the ...
Read Full Story »

Genentech To Set Biotech Sector Earnings Bias (DNA)

Posted: October 15, 2007 at 11:26 am

Genentech Inc. (NYSE:DNA) is set to report earnings after today's close. First Call has consensus estimates at $0.72 EPS on $2.93 Billion in revenues.  The biotech giant usually offers guidance ...
Read Full Story »

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

Posted: August 22, 2007 at 11:04 am

ADNEXUS THERAPEUTICS, INC. has filed to come public via an IPO with the filed amount to sell up to $86,250,000 in common stock.  Adnexus has taken the proposed ADNX ticker ...
Read Full Story »